AZ’s ADC receives priority review
US FDA provides AZ and Daiichi Sankyo’s ADC for the treatment of metastatic breast cancer priority review, with a decision set for Q2 2020.
Archives for October 17, 2019
Glenmark spins out bispecific portfolio through Ichnos
Ichnos will launch with a portfolio of five clinical stage assets, a proprietary platform, as well as a biologics manufacturing facility and 350 employees.